| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.556 | 29.797 | 37.264 | 47.437 | 42.536 | 37.094 | 65.268 | 73.562 | 81.316 | 91.384 |
| Total Income - EUR | 19.556 | 29.797 | 37.513 | 47.673 | 42.536 | 37.316 | 65.268 | 73.653 | 82.336 | 91.993 |
| Total Expenses - EUR | 13.238 | 11.356 | 25.658 | 29.103 | 37.141 | 10.380 | 23.207 | 18.549 | 33.207 | 40.458 |
| Gross Profit/Loss - EUR | 6.318 | 18.441 | 11.855 | 18.570 | 5.395 | 26.935 | 42.061 | 55.104 | 49.128 | 51.535 |
| Net Profit/Loss - EUR | 5.731 | 17.547 | 10.737 | 17.140 | 4.119 | 25.855 | 40.103 | 53.362 | 48.305 | 48.775 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - C & A Uromedical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.812 | 4.950 | 24.208 | 19.998 | 3.107 | 3.016 | 3.844 | 3.078 | 3.266 | 2.404 |
| Current Assets | 13.256 | 24.136 | 25.009 | 25.250 | 38.186 | 61.413 | 82.771 | 32.456 | 49.158 | 43.653 |
| Inventories | 1.834 | 3.212 | 3.144 | 0 | 0 | 0 | 733 | 0 | 0 | 216 |
| Receivables | 0 | 0 | 1.887 | 70 | 0 | 2.755 | 341 | 11.510 | 13.729 | 10.595 |
| Cash | 11.422 | 20.924 | 19.978 | 25.180 | 38.186 | 58.658 | 81.697 | 20.947 | 35.429 | 32.842 |
| Shareholders Funds | 9.504 | 17.605 | 10.794 | 17.204 | 20.990 | 46.447 | 67.007 | 21.375 | 45.509 | 28.991 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.564 | 11.481 | 38.423 | 28.044 | 20.303 | 17.982 | 19.609 | 14.160 | 6.915 | 17.067 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - C & A Uromedical Srl